DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Ryan CJ, Smith MR, Fong L. et al
Phase I clinical trial of the CYP17 inhibitor abiraterone acetate demonstrating clinical activity in patients with castration-resistant prostate cancer who received prior ketoconazole therapy.
J Clin Oncol 2010;
28 (09) 1481-1488
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.